EBV-Related Malignant Neoplasm — Trials

EBV-Related Malignant Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

120 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 20
Recruiting: 8
Ph III recruiting: 0
Growth YoY: —
Industry share: 10%
Top sponsor: National Cancer Institute (NCI)
Termination share: 39.6%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (26)

clinicaltrialsPublishedShowing 51–54 of 54 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT01652014	Single or Double Donor Umbilical Cord Blood Transplant in Treating Patients With High-Risk Hematologic Malignancies	withdrawn	Phase 2	0	University of Medicine and Dentistry of New JerseyOTHER	1	Jul 14, 2016	clinicaltrials
NCT00089076	MDX-010 in Treating Patients With Recurrent or Refractory Lymphoma	terminated	Phase 1 / Phase 2	18	National Cancer Institute (NCI)NIH	1	May 30, 2014	clinicaltrials